Mitch Frazier: One Health holds promise for Indiana and the world
While no single solution exists to overcome America’s health woes, the next wave of breakthroughs could emerge at the intersection of farms, feed lots, food and pharmaceuticals.
While no single solution exists to overcome America’s health woes, the next wave of breakthroughs could emerge at the intersection of farms, feed lots, food and pharmaceuticals.
Attorney General Todd Rokita said the lawsuit, filed last Wednesday in the Lake County Superior Court, is part of his office’s intensifying efforts to lower insulin prices and improve health care affordability.
A former Hoosier lawmaker and a former Irish government minister are linking their firms as Indiana’s ties to Ireland grow.
Novo Nordisk is aiming to avoid losing ground to its main rival, Eli Lilly, which is seeking regulatory approval for its own GLP-1 weight-loss pill.
Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.
Ventyx is a San Diego-based biotech that specializes in drugs for inflammatory diseases like Crohn’s and rheumatoid arthritis.
Indianapolis-based Eli Lilly and Co. announced Wednesday it intends to acquire Ventyx Biosciences, a clinical-stage biopharmaceutical company developing oral therapies for inflammatory-mediated diseases.
The plant will focus on serving health care companies by developing and commercializing medical devices, drug delivery systems and combination products.
People who stop taking GLP-1 drugs such as Ozempic, Wegovy and Zepbound for weight loss are projected to regain their shed pounds within about 1-½ years, a review of existing research has found.
Courtney Roberts’ job is to help ensure that when children with serious illnesses, injuries and conditions must be in the hospital, Riley Health is fully funded to meet their medical and care needs and to advance research to also improve care.
I do not fault Lilly for making its charitable donation to IU. Over the years, Lilly has been extremely generous to our city and state in various ways.
The new initiative expands on the massive artificial intelligence supercomputer collaboration the companies announced last fall.
U.S. Food and Drug Administration officials say a comprehensive review “found no increased risk” related to suicide among users of the GLP-1 drugs, including Eli Lilly and Co.’s Zepbound, used to treat obesity.
The $20 million donation to the Indiana University Health Foundation by Sarah and John Lechleiter and Deborah and Randall Tobias was the largest contribution by Indiana givers to an Indiana organization last year.
Ovarian cancer is the fifth-leading cause of cancer death among women in the United States.
The fund has secured commitments from Eli Lilly and Co., Corteva Inc., Elanco Animal Health, Indiana University, Parkview Health and the Indiana Economic Development Corp.
“The Indy Chamber is where business and community come together to move central Indiana forward,” Harrison said in a statement.
The agreement with Seamless is the latest in a series of purchases and partnerships Lilly has established to build a pipeline of genetic medicines.
The new facility, part of a $27 billion reshoring investment, will produce the drugmaker’s weight-loss therapies.
Eli Lilly and Co. has announced $50 billion in U.S. expansion commitments since 2020, including numerous manufacturing plants all over the country.